Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diarylamine Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101723891A details a novel route for diarylamines using N-aryl carbamates, offering high purity and yield for p38 kinase inhibitors.